Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE)

Inclusion Criteria: * Age: Adult males aged 30 to 75 years. * Diagnosis: Confirmed diagnosis of erectile dysfunction (ED) of mild to moderate severity, as defined by an International Index of Erectile Function (IIEF) score. * Treatment Response: Failure or suboptimal response to conventional ED treatments, such as PDE-5 inhibitors. * General Health: Overall good health without contraindications to stem cell therapy. * Informed Consent: Ability and willingness to provide written informed consent to participate in the study. Exclusion Criteria: * Severe Cardiovascular Disease: Presence of severe cardiovascular conditions, including uncontrolled hypertension or significant heart disease. * Active Infections: Ongoing infections that could interfere with treatment or pose a risk to the participant. * Malignancies: History of or current cancer, including malignancies that could affect safety or treatment outcomes. * Contraindications to Stem Cell Therapy: Any medical conditions or treatments that contraindicate the use of stem cell therapy. * Uncontrolled Diabetes: Poorly controlled diabetes or other metabolic disorders that could impact treatment efficacy or safety. * Psychiatric or Cognitive Impairments: Significant psychiatric or cognitive disorders that may affect the participant\'s ability to comply with study protocols or provide informed consent. * Recent Surgery or Trauma: Recent major surgeries or physical trauma that could impact the study or interfere with the intervention. * Participation in Other Studies: Participation in other clinical trials or studies that may affect the outcomes or safety of this study.